- Home
- CCCC
CCCC
C4 Therapeutics Inc.
as 11-21-2024 12:32pm EST
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | WATERTOWN |
| Market Cap: | 396.0M | IPO Year: | 2020 |
| Target Price: | $10.00 | AVG Volume (30 days): | 977.7K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.63 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.06 - $11.88 | Next Earning Date: | 10-31-2024 |
| Revenue: | $33,668,000 | Revenue Growth: | 65.45% |
| Revenue Growth (this year): | 76.74% | Revenue Growth (next year): | -55.37% |
Latest C4 Therapeutics Inc. News
CCCC Breaking Stock News: Dive into CCCC Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors
GlobeNewswire
15 days ago
C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial
GlobeNewswire
16 days ago
C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at the American Society of Hematology (ASH) Annual Meeting
Simply Wall St.
20 days ago
C4 Therapeutics Third Quarter 2024 Earnings: Beats Expectations
Zacks
21 days ago
C4 Therapeutics, Inc. (CCCC) Reports Q3 Loss, Tops Revenue Estimates
GlobeNewswire
21 days ago
C4 Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Simply Wall St.
23 days ago
We're Hopeful That C4 Therapeutics (NASDAQ:CCCC) Will Use Its Cash Wisely
GlobeNewswire
24 days ago
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Compare CCCC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CCCC C4 Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.